Brazil extends cancer network
This article was originally published in Clinica
Executive Summary
Maceio, the capital of the Brazilian state of Alagoas, is to get a high-technology oncology centre, for which the government has pledged R$2.4 million (US$1 million), under the national cancer care expansion programme, Expande. The Cacon centre, based at the Professor Alberto Antunes university hospital, will be equipped to provide diagnostics, clinical and surgical oncology, radiotherapy, haemotherapy and rehabilitation, among others, under the national health system (SUS). When it opens in September 2002, it will have a capacity to treat around 715,000 patients. Eventually, it aims to cover the cancer care needs of half of the state's population, compared with some 22% of the population at present.
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.